Related Experiment Videos
Unresolved issues in osteoporosis in men.
1Austin & Repatriation Medical Center, University of Melbourne, Melbourne, Australia.
Reviews in Endocrine & Metabolic Disorders
|November 14, 2001
Summary
Fragility fractures in men are a growing public health concern. Research indicates bone density and structural differences, not just lower incidence, contribute to fracture risk in men.
Area of Science:
- Gerontology
- Orthopedics
- Public Health
Background:
- Fragility fractures pose a significant public health challenge in aging men.
- While approximately one-third of hip fractures occur in men, incidence and gender ratios vary globally.
- The underlying causes of higher male mortality post-fracture and differing fracture incidence compared to women require further investigation.
Purpose of the Study:
- To investigate the factors contributing to fragility fractures in men.
- To understand the role of bone mineral density, bone structure, and hormonal influences in male fracture risk.
- To identify knowledge gaps in the prevention and treatment of fractures in men.
Main Methods:
- Review of existing literature on male fragility fractures.
- Analysis of bone mineral density (aBMD) and volumetric bone mineral density (vBMD) data in relation to fracture risk.
- Exploration of potential contributing factors including hypogonadism and bone remodeling processes.
Main Results:
- Areal bone mineral density (aBMD) and prevalent fractures predict fracture risk similarly in men and women.
- Age-specific absolute risks for hip and spine fractures are comparable between sexes for a given aBMD.
- Lower fracture incidence in men may be linked to population distribution of bone size, vBMD, and architecture, alongside higher mortality and fewer falls.
Conclusions:
- The tail end of the male population distribution for bone traits likely accounts for fracture cases.
- Hypogonadism is a risk factor, but its precise definition, prevalence, and structural consequences remain unclear.
- Significant knowledge gaps persist regarding hormonal regulation of bone strength and the mechanisms of bone loss in men.